Feature|Articles|April 24, 2026

AAD 2026 Insights: Expanding Targets, Faster Responses, and Durable Control in Atopic Dermatitis Management

Author(s)Kaitlyn Bader, Assistant Managing Editor

Gain exclusive insights from AAD on rapid-onset topicals, durable biologic control, and a growing emphasis on stringent, patient-centered targets shaping atopic dermatitis care.

New data presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, highlighted substantial advances in atopic dermatitis (AD), spanning topical, biologic, and systemic approaches. Across multiple studies, investigators reported earlier onset of action, sustained long-term disease control, and improved patient-reported outcomes tied to more stringent treatment targets.